Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
The Journal of Nutrition|March 3, 2017
Food Insecurity Is Associated with Subjective Well-Being among Individuals from 138 Countries in the 2014 Gallup World PollEdward A Frongillo, Hoa T Nguyen, Michael D Smith, et al.
The Journal of Nutrition|January 1, 2019
Food Insecurity Is More Strongly Associated with Poor Subjective Well-Being in More-Developed Countries than in Less-Developed CountriesEdward A Frongillo, Hoa T Nguyen, Michael D Smith, et al.
Archives of Sexual Behavior|August 15, 2014
Social-emotional aspects of male escorting: experiences of men working for an agencyMichael D Smith, Christian Grov, David W Seal, et al.
Journal of Sex Research|August 7, 2013
Male clients of male escorts: satisfaction, sexual behavior, and demographic characteristicsChristian Grov, Margaret Wolff, Michael D Smith, et al.
Pain Medicine (Malden, Mass.)|January 28, 2016
A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of OxycodoneLynn R Webster, Ernest A Kopecky, Michael D Smith, et al.
Journal of Clinical Microbiology|October 7, 2005
Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detectionJohn P Leeming, Keith Cartwright, Rhonwen Morris, et al.
Pain Medicine (Malden, Mass.)|September 17, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) versus Extended-Release Morphine Administered Orally in Nondependent Recreational Opioid UsersMichael D Smith, Lynn R Webster, John Lawler, et al.
Annals of Emergency Medicine|June 21, 2011
A comparison of patient and staff attitudes about emergency department-based HIV testing in 2 urban hospitalsCarrie R Hecht, Michael D Smith, Karina Radonich, et al.
Pain Medicine (Malden, Mass.)|September 22, 2016
Human Abuse Potential of an Abuse-Deterrent (AD), Extended-Release (ER) Morphine Product Candidate (Morphine-ADER Injection-Molded Tablets) vs Extended-Release Morphine Administered Intranasally in Nondependent Recreational Opioid UsersLynn R Webster, Michael D Smith, John Lawler, et al.
The Journal of Clinical Psychiatry|February 9, 2012
An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHDSuzanne M Sutherland, Lenard A Adler, Crystal Chen, et al.
Pageof 12